ADC Therapeutics SA
ADCT
$1.29
-$0.02-1.15%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.57M | -32.97M | -6.41M | -40.97M | -56.65M |
| Total Depreciation and Amortization | -114.00K | 114.00K | 113.00K | 122.00K | -459.00K |
| Total Amortization of Deferred Charges | 940.00K | 225.00K | 246.00K | 733.00K | 650.00K |
| Total Other Non-Cash Items | -8.40M | 7.92M | -13.49M | 10.09M | 17.02M |
| Change in Net Operating Assets | 12.33M | -5.01M | -11.58M | 392.00K | 15.35M |
| Cash from Operations | -11.81M | -29.71M | -31.12M | -29.63M | -24.09M |
| Capital Expenditure | 0.00 | -32.00K | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | 659.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -32.00K | 659.00K | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 118.00K | 205.00K | 58.35M | -- | 94.03M |
| Repurchase of Common Stock | -217.00K | -768.00K | -1.26M | -198.00K | -250.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -20.00K | -- | -- | -- |
| Cash from Financing | -99.00K | -583.00K | 57.09M | -198.00K | 93.78M |
| Foreign Exchange rate Adjustments | 5.00K | -5.00K | -25.00K | 6.00K | 163.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.90M | -30.33M | 26.60M | -29.82M | 69.86M |